NYSE:INSP - Inspire Medical Systems Stock Price, Forecast & News

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Inspire Medical Systems (NYSE:INSP) released its earnings results on Tuesday, November, 5th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.09. The business had revenue of $20.86 million for the quarter, compared to analyst estimates of $19.15 million. Inspire Medical Systems had a negative return on equity of 18.67% and a negative net margin of 40.36%. Inspire Medical Systems's revenue was up 59.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.22) earnings per share. View Inspire Medical Systems' Earnings History.

Inspire Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Inspire Medical Systems.

3 analysts have issued 1-year price targets for Inspire Medical Systems' shares. Their forecasts range from $51.00 to $78.00. On average, they anticipate Inspire Medical Systems' share price to reach $68.00 in the next year. This suggests that the stock has a possible downside of 5.2%. View Analyst Price Targets for Inspire Medical Systems.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inspire Medical Systems.

News stories about INSP stock have trended somewhat negative recently, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inspire Medical Systems earned a news impact score of -1.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Inspire Medical Systems.

Inspire Medical Systems saw a decrease in short interest in November. As of November 29th, there was short interest totalling 1,160,000 shares, a decrease of 12.8% from the November 14th total of 1,330,000 shares. Based on an average trading volume of 243,600 shares, the days-to-cover ratio is presently 4.8 days. Approximately 5.2% of the shares of the stock are short sold. View Inspire Medical Systems' Current Options Chain.

Some companies that are related to Inspire Medical Systems include Haemonetics (HAE), Globus Medical (GMED), Penumbra (PEN), Integra Lifesciences (IART), NuVasive (NUVA), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Nevro (NVRO), Cantel Medical (CMD), Glaukos (GKOS), Merit Medical Systems (MMSI), Cardiovascular Systems (CSII), Irhythm Technologies (IRTC), Atrion (ATRI) and Tactile Systems Technology (TCMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Alibaba Group (BABA), Splunk (SPLK), Twilio (TWLO), Bank of America (BAC), Netflix (NFLX), NVIDIA (NVDA), Paypal (PYPL), Verizon Communications (VZ), Zscaler (ZS) and salesforce.com (CRM).

(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Columbus Circle Investors (2.56%), TimesSquare Capital Management LLC (2.26%), Gilder Gagnon Howe & Co. LLC (1.19%), State Street Corp (1.13%), Castleark Management LLC (0.76%) and Massachusetts Financial Services Co. MA (0.72%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Mudit K Jain, Orbimed Advisors Llc, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.

INSP stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Kornitzer Capital Management Inc. KS, Russell Investments Group Ltd., State Street Corp, Squarepoint Ops LLC, Dupont Capital Management Corp, Public Employees Retirement System of Ohio and Massachusetts Financial Services Co. MA. Company insiders that have sold Inspire Medical Systems company stock in the last year include Casey M Tansey, Joyce Erony, Marilyn C Nelson, Mudit K Jain, Orbimed Advisors Llc, Randy Ban, Richard Buchholz and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.

INSP stock was purchased by a variety of institutional investors in the last quarter, including Man Group plc, First Trust Advisors LP, State of New Jersey Common Pension Fund D, Endurant Capital Management LP, TimesSquare Capital Management LLC, Calamos Advisors LLC, SG Americas Securities LLC and WCM Investment Management LLC. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.

Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of INSP stock can currently be purchased for approximately $71.75.

Inspire Medical Systems has a market capitalization of $1.73 billion and generates $50.59 million in revenue each year. The company earns $-21,830,000.00 in net income (profit) each year or ($1.50) on an earnings per share basis. View Additional Information About Inspire Medical Systems.

The official website for Inspire Medical Systems is http://www.inspiresleep.com/.

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The company can be reached via phone at 844-672-4357 or via email at [email protected]